MT:EURONEXT AMSTERDAMArcelorMittal SA Analysis
Data as of 2026-08-30 - not real-time
$74.39
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
ArcelorMittal S.A. is priced at $74.39 and its moving averages line up in bullish order, the shorter sitting above the longer. Over a rolling month the price has gained 11.9%. Momentum indicators put RSI at 59.1 (neutral) with MACD reading bearish. Watch $69.29 as support and $75.93 as the nearer resistance level.
Multiples put this in fair territory at a P/E of 31.4. Revenue is growing at 5.2% on a 2.9% profit margin. The 0.80% dividend yield looks covered by current payout levels.
On a 1-10 scale the risk profile lands at 7 — elevated. With 30-day volatility of 32.7%, a beta of 2.09 and a maximum drawdown of 28.8%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 96 on the fear-greed composite.
The horizons line up on hold — conviction 2 out of 10.
Multiples put this in fair territory at a P/E of 31.4. Revenue is growing at 5.2% on a 2.9% profit margin. The 0.80% dividend yield looks covered by current payout levels.
On a 1-10 scale the risk profile lands at 7 — elevated. With 30-day volatility of 32.7%, a beta of 2.09 and a maximum drawdown of 28.8%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 96 on the fear-greed composite.
The horizons line up on hold — conviction 2 out of 10.
Top Market Events
31 July 2026, 20:30 CET ArcelorMittal has today published its half-year report for the six-month period ended 30 June...ArcelorMittal stock reacts to fresh analyst coverage on August 24, 2026, with a new Overweight ratinYahoo Finance1monArcelorMittal SA MT Q2 2026 Earnings Call Highlights: Strong EBITDA and Counter-Seasonal .
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 3/10
Key Factors
- Short-term moving averages stacked above long-term ones
- Trading above the 200-day average of 58.46
- MACD momentum is negative
Medium Term
1–3 yearsNeutral
Model confidence: 2/10
Key Factors
- Short-term moving averages stacked above long-term ones
- Trading above the 200-day average of 58.46
- MACD momentum is negative
Long Term
> 3 yearsNeutral
Model confidence: 2/10
Key Factors
- Negative free cash flow
- P/E ratio of 31.4
- Dividend yield of 0.80%
Key Metrics & Analysis
Financial Health
Revenue Growth5.20%
Profit Margin2.88%
P/E Ratio31.4
ROE3.28%
ROA1.63%
Debt/Equity25.38
P/B Ratio2.0
Op. Cash Flow$4.7B
Free Cash Flow$-779124992
Technical Analysis
TrendBullish
RSI59.1
Support$69.29
Resistance$75.93
MA 20$73.56
MA 50$68.23
MA 200$58.46
MACDBearish
VolumeIncreasing
Fear & Greed Index95.66
Valuation
Fair Value$57.22
Target Price$76.20
Upside/Downside2.43%
GradeFair
TypeGrowth
Dividend Yield0.80%
Risk Assessment
Beta2.09
Volatility32.67%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.